IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K405. A total of 56 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 2,274 | -76.8% | 0.00% | – |
| Q3 2021 | $11,000 | 0.0% | 9,822 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -96.0% | 9,822 | -95.3% | 0.00% | – |
| Q1 2021 | $274,000 | +2640.0% | 211,158 | +7262.6% | 0.00% | – |
| Q4 2020 | $10,000 | – | 2,868 | +6895.1% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 41 | -96.1% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 1,051 | +3.1% | 0.00% | – |
| Q1 2020 | $1,000 | -90.9% | 1,019 | -75.7% | 0.00% | – |
| Q2 2019 | $11,000 | 0.0% | 4,202 | -9.5% | 0.00% | – |
| Q1 2019 | $11,000 | – | 4,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 56,250 | $206,000 | 0.12% |
| Baker Brothers Advisors | 4,608,786 | $16,914,000 | 0.06% |
| Artal Group S.A. | 500,000 | $1,835,000 | 0.04% |
| HOLLENCREST CAPITAL MANAGEMENT | 90,000 | $331,000 | 0.04% |
| Spotlight Asset Group, Inc. | 21,500 | $79,000 | 0.03% |
| DCF Advisers, LLC | 18,755 | $69,000 | 0.03% |
| 683 Capital Management, LLC | 88,470 | $325,000 | 0.02% |
| Palo Alto Investors LP | 77,044 | $283,000 | 0.02% |
| Alpine Global Management, LLC | 13,966 | $51,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 4,000 | $15,000 | 0.01% |